Osakidetza
Also known as: Araba University | Asociacion Instituto Biodonostia | Basque Health Service: Araba University Hospital | Basque Health Service: Donosti University Hospital | Biodonostia Health Research Institute | Complejo Hospitalario de Donostia | Cruces Hospital, Bilbao | Donosti University | Hospital Cruces | Hospital de Cruces, Baracaldo | Hospital de Cruces, Bilbao | Hospital de Cruces de Baracaldo - Bilbao | Hospital de Cruces de Baracaldo, Bilbao | Hospital de Donostia | Hospital de Donostia. Neurology Department | Hospital Donostia | Hospital Universitario Araba | Hospital Universitario Araba (Sede Txogoriritxu) | Hospital Universitario Donostia | HOSPITAL UNIVERSITARIO DONOSTIA | Hospital Universitario Donostia, San Sebastián, Spain. | IBON JAUNARENA | INSTITUTO BIODONOSTIA | Osakidetza | Osakidetza- Basque HS
Highest phase reached
Phase 4
First clinical trial
Jan 1, 2004Last known activity
Jun 1, 2023
Timeline
2000s
- Jun 1, 2002
Osakidetza— Founded
Drugs by trial phase (59 distinct, 35 trials)
Phase 4 (22 own, 0 via acquisition)
Phase 3 (15 own, 0 via acquisition)
Phase 2 (15 own, 0 via acquisition)
Phase 1 (5 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Studied for
- Acquired Immunodeficiency Syndrome
- Adenocarcinoma
- Breast Neoplasms
- Breech Presentation
- Carcinoma
- Carcinoma, Hepatocellular
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Small Cell
- Chronic Pain
- Colonic Neoplasms
- Communicable Diseases
- Conjunctivitis
- Cysts
- Esophageal Neoplasms
- HIV Infections
- Infections
- Infertility
- Kidney Diseases
- Liver Diseases
- Lung Neoplasms
- Lymphohistiocytosis, Hemophagocytic
- Multiple Myeloma
- Neoplasm Metastasis
- Neoplasms, Plasma Cell
- Neoplasms, Second Primary
- Neuroendocrine Tumors
- Osteogenesis Imperfecta
- Ovarian Hyperstimulation Syndrome
- Pancreatic Neoplasms
- Placental Insufficiency
- Polycystic Kidney, Autosomal Dominant
- Polycystic Kidney Diseases
- Pre-Eclampsia
- Pregnancy Complications
- Recurrence
- Respiratory Insufficiency
- Small Cell Lung Carcinoma
- Stomach Neoplasms
- Stroke
- Thrombosis
- Ulcer
- Varicose Ulcer
Recent trials (47)
- NCT05797792OfficialPhase 3Jun 1, 2023
- NCT05583110OfficialPhase 2Feb 1, 2023
- NCT05489185Lead sponsorPhase 4Sep 1, 2022
- NCT04997551Lead sponsorPhase 3Sep 8, 2020
- NCT05002517Lead sponsorPhase 3Sep 3, 2020
- NCT02994550Lead sponsorEarly Phase 1Jan 1, 2017
- NCT02994550Reponsible party - principal investigatorEarly Phase 1Jan 1, 2017
- NCT02958150Overall official - principal investigatorPhase 4Oct 1, 2016
- NCT02833116Overall official - principal investigatorPhase 4Jun 1, 2016
- NCT02833116Study directorPhase 4Jun 1, 2016
- NCT02709720Overall official - principal investigatorPhase 2Apr 1, 2016
- NCT02587143CollaboratorN/AFeb 1, 2016
- NCT02391662Study chairPhase 2May 1, 2015
- NCT02213952CollaboratorPhase 3Jan 31, 2015
- NCT02439398CollaboratorPhase 1/Phase 2Jun 30, 2014
Details
- Founded
- Bilbao, ES Jun 1, 2002
- Last known activity
- Jun 1, 2023